3D Structure of Ghrelin and Its Truncated Analogs Reveals How the Fatty Acid Tag Enables Function

NMR structural analysis of ghrelin and six truncated versions showed the octanoyl modification on serine-3 stabilizes a turn structure in the N-terminal active region, explaining why this lipid tag is essential for receptor activation.

Silva Elipe, M V et al.·Biopolymers·2001·Preliminary Evidencein-vitro
RPEP-00698In VitroPreliminary Evidence2001RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

The octanoyl modification on Ser3 stabilizes a turn structure in ghrelin's N-terminal active core (first 5 residues), explaining its essential role in receptor binding and activation at the structural level.

Key Numbers

How They Did This

NMR structural study determining solution structures of human ghrelin and six N-terminally truncated analogs in membrane-mimetic environments. Structure-activity correlation with known receptor binding data.

Why This Research Matters

Understanding why ghrelin needs its fatty acid tag at the atomic level enables rational design of drugs that mimic this structure — essential for creating effective oral ghrelin-based therapeutics.

The Bigger Picture

Ghrelin's structural biology is key to converting it from a research peptide into a drug. This atomic-level understanding of the octanoyl requirement has directly informed the design of ghrelin mimetics now in clinical development.

What This Study Doesn't Tell Us

NMR structures in membrane-mimetic solvent may differ from receptor-bound conformation. Truncated analogs may not fold identically to corresponding regions in full-length ghrelin.

Questions This Raises

  • ?Can the octanoyl turn structure be mimicked by a non-lipid chemical group?
  • ?Does the active core structure change upon receptor binding?
  • ?Could longer-chain fatty acids improve stability or potency?

Trust & Context

Key Stat:
Structural explanation The octanoyl group on Ser3 stabilizes a turn in the first 5 amino acids — the atomic-level reason ghrelin needs its fatty acid tag to function
Evidence Grade:
Preliminary structural biology evidence with clear structure-activity correlation from seven related peptide structures.
Study Age:
Published in 2001. These structural insights have directly guided ghrelin analog and mimetic drug design over the following two decades.
Original Title:
1H NMR structural analysis of human ghrelin and its six truncated analogs.
Published In:
Biopolymers, 59(7), 489-501 (2001)
Database ID:
RPEP-00698

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Why does ghrelin need a fatty acid to work?

The fatty acid (octanoyl) group locks a specific shape in ghrelin's active region. Without it, the peptide is too floppy to fit properly into its receptor. This is like needing a key to be rigid to turn a lock.

How does this help make ghrelin drugs?

Knowing the exact shape the fatty acid creates allows drug designers to build molecules that adopt this same shape without the fatty acid — creating more stable, drug-like compounds that can be taken orally.

Read More on RethinkPeptides

Cite This Study

RPEP-00698·https://rethinkpeptides.com/research/RPEP-00698

APA

Silva Elipe, M V; Bednarek, M A; Gao, Y D. (2001). 1H NMR structural analysis of human ghrelin and its six truncated analogs.. Biopolymers, 59(7), 489-501.

MLA

Silva Elipe, M V, et al. "1H NMR structural analysis of human ghrelin and its six truncated analogs.." Biopolymers, 2001.

RethinkPeptides

RethinkPeptides Research Database. "1H NMR structural analysis of human ghrelin and its six trun..." RPEP-00698. Retrieved from https://rethinkpeptides.com/research/silva-2001-1h-nmr-structural-analysis

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.